Dr. Criego is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Park Nicollet Blvd
Minneapolis, MN 55416Phone+1 952-993-3900Fax+1 952-993-1761
Education & Training
University of MinnesotaFellowship, Pediatric Endocrinology, 2002 - 2005
University of MinnesotaMS, Clinical Research , 2002 - 2005
Corewell Health Helen DeVos Children's Hospital/Michigan State UniversityResidency, Pediatrics, 1999 - 2002
University of North Dakota School of Medicine and Health SciencesClass of 1999
Certifications & Licensure
MN State Medical License 2003 - 2025
WI State Medical License 2014 - 2015
MI State Medical License 1999 - 2002- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Threshold Suspend in Pediatrics at Home Start of enrollment: 2014 Jun 01
- Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home Start of enrollment: 2017 May 25
- Day and Night Closed-loop in Young People With Type 1 Diabetes Start of enrollment: 2017 May 12
- Join now to see all
Publications & Presentations
PubMed
- Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes.Sarah A MacLeish, Korey K Hood, William H Polonsky, Jamie R Wood, Bruce W Bode
Diabetes, Obesity & Metabolism. 2024-12-01 - 2 citationsExpert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens.Gregg D Simonson, Amy B Criego, Tadej Battelino, Anders L Carlson, Pratik Choudhary
Diabetes Technology & Therapeutics. 2024-11-01 - 4 citationsGlycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod5 Automated Insulin Delivery System.Daniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, Lori M Laffel, Bruce A Buckingham
Diabetes Technology & Therapeutics. 2024-06-01
Press Mentions
- Flash Glucose Monitoring Reduces Rate of Acute Diabetes Events 2 Years After InitiationAugust 19th, 2022
- Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes at 12 Months of Use in Children 2 to 5.9 Years of AgeJune 3rd, 2022
- CGM as Medicine: Technology Benefits Extend to Type 2 DiabetesNovember 22nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
